submitter_follow_up_id,program_id,submitter_donor_id,submitter_primary_diagnosis_id,submitter_treatment_id,date_of_followup,disease_status_at_followup,relapse_type,date_of_relapse,method_of_progression_status,anatomic_site_progression_or_recurrence
FOLLOW_UP_0001,SYNTH_01,DONOR_0001,DIAG_0001,,"{'day_interval': 1639, 'month_interval': 53}",Distant progression,Progression (liquid tumours),"{'day_interval': 1498, 'month_interval': 49}",Imaging (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0002,SYNTH_01,DONOR_0002,,TREATMENT_0003,"{'day_interval': 748, 'month_interval': 24}",Stable,Progression (liquid tumours),,Physical examination procedure (procedure)|Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0003,SYNTH_01,DONOR_0003,,,"{'day_interval': 1297, 'month_interval': 42}",Loco-regional progression,Biochemical progression,"{'day_interval': 311, 'month_interval': 10}",Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0004,SYNTH_01,DONOR_0004,DIAG_0004,,,Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 117, 'month_interval': 3}",Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0005,SYNTH_01,DONOR_0005,,TREATMENT_0009,,Complete remission,Progression (liquid tumours),,Assessment of symptom control (procedure)|Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0006,SYNTH_01,DONOR_0006,,,"{'day_interval': 571, 'month_interval': 18}",Progression not otherwise specified,Local recurrence and distant metastasis,"{'day_interval': 62, 'month_interval': 2}",Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0007,SYNTH_01,DONOR_0007,DIAG_0007,,,Stable,Biochemical progression,,Imaging (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0008,SYNTH_01,DONOR_0008,,TREATMENT_0015,"{'day_interval': 1013, 'month_interval': 33}",Stable,Local recurrence and distant metastasis,,Laboratory data interpretation (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0009,SYNTH_01,DONOR_0009,,,"{'day_interval': 940, 'month_interval': 30}",,Biochemical progression,,Histopathology test (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0010,SYNTH_01,DONOR_0010,DIAG_0010,,,Partial remission,Biochemical progression,,Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0011,SYNTH_02,DONOR_0021,,TREATMENT_0041,,,Biochemical progression,,Histopathology test (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0012,SYNTH_02,DONOR_0022,,,"{'day_interval': 9607, 'month_interval': 315}",Stable,Local recurrence,,Tumor marker measurement (procedure)|Histopathology test (procedure),
FOLLOW_UP_0013,SYNTH_02,DONOR_0023,DIAG_0023,,"{'day_interval': 1420, 'month_interval': 46}",Partial remission,Distant recurrence/metastasis,,Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure),
FOLLOW_UP_0014,SYNTH_02,DONOR_0024,,TREATMENT_0047,"{'day_interval': 722, 'month_interval': 23}",Complete remission,Biochemical progression,,Assessment of symptom control (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0015,SYNTH_02,DONOR_0025,,,"{'day_interval': 4758, 'month_interval': 156}",Complete remission,Progression (liquid tumours),,Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0016,SYNTH_02,DONOR_0026,DIAG_0026,,"{'day_interval': 1581, 'month_interval': 51}",,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0017,SYNTH_02,DONOR_0027,,TREATMENT_0053,"{'day_interval': 658, 'month_interval': 21}",No evidence of disease,Progression (liquid tumours),,Histopathology test (procedure)|Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0018,SYNTH_02,DONOR_0028,,,"{'day_interval': 1924, 'month_interval': 63}",Complete remission,Biochemical progression,,Physical examination procedure (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0019,SYNTH_02,DONOR_0029,DIAG_0029,,"{'day_interval': 800, 'month_interval': 26}",Stable,Biochemical progression,,Histopathology test (procedure)|Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0020,SYNTH_02,DONOR_0030,,TREATMENT_0059,,Relapse or recurrence,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0021,SYNTH_03,DONOR_0041,,,"{'day_interval': 5349, 'month_interval': 175}",No evidence of disease,Progression (liquid tumours),,Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0022,SYNTH_03,DONOR_0042,DIAG_0042,,"{'day_interval': 1534, 'month_interval': 50}",Complete remission,Local recurrence,,Laboratory data interpretation (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0023,SYNTH_03,DONOR_0043,,TREATMENT_0085,"{'day_interval': 676, 'month_interval': 22}",Stable,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0024,SYNTH_03,DONOR_0044,,,"{'day_interval': 407, 'month_interval': 13}",No evidence of disease,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Histopathology test (procedure),
FOLLOW_UP_0025,SYNTH_03,DONOR_0045,DIAG_0045,,"{'day_interval': 465, 'month_interval': 15}",Progression not otherwise specified,Progression (liquid tumours),"{'day_interval': 167, 'month_interval': 5}",Assessment of symptom control (procedure)|Histopathology test (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0026,SYNTH_03,DONOR_0046,,TREATMENT_0091,"{'day_interval': 757, 'month_interval': 24}",Progression not otherwise specified,Local recurrence and distant metastasis,"{'day_interval': 144, 'month_interval': 4}",Laboratory data interpretation (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0027,SYNTH_03,DONOR_0047,,,"{'day_interval': 4603, 'month_interval': 151}",,Biochemical progression,,Laboratory data interpretation (procedure)|Tumor marker measurement (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0028,SYNTH_03,DONOR_0048,DIAG_0048,,"{'day_interval': 1945, 'month_interval': 63}",,Distant recurrence/metastasis,,Histopathology test (procedure)|Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0029,SYNTH_03,DONOR_0049,,TREATMENT_0097,,Partial remission,Biochemical progression,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Histopathology test (procedure),
FOLLOW_UP_0030,SYNTH_03,DONOR_0050,,,"{'day_interval': 819, 'month_interval': 26}",,Biochemical progression,,Physical examination procedure (procedure)|Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0031,SYNTH_04,DONOR_0061,DIAG_0061,,"{'day_interval': 3236, 'month_interval': 106}",Progression not otherwise specified,Local recurrence and distant metastasis,,Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0032,SYNTH_04,DONOR_0062,,TREATMENT_0123,,Stable,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Imaging (procedure)|Histopathology test (procedure),
FOLLOW_UP_0033,SYNTH_04,DONOR_0063,,,,Complete remission,Local recurrence,,Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0034,SYNTH_04,DONOR_0064,DIAG_0064,,,Distant progression,Distant recurrence/metastasis,"{'day_interval': 460, 'month_interval': 15}",Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0035,SYNTH_04,DONOR_0065,,TREATMENT_0129,"{'day_interval': 910, 'month_interval': 29}",Partial remission,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0036,SYNTH_04,DONOR_0066,,,"{'day_interval': 8691, 'month_interval': 285}",Loco-regional progression,Local recurrence,"{'day_interval': 3845, 'month_interval': 126}",Laboratory data interpretation (procedure)|Physical examination procedure (procedure)|Histopathology test (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0037,SYNTH_04,DONOR_0067,DIAG_0067,,"{'day_interval': 3318, 'month_interval': 109}",Complete remission,Biochemical progression,,Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0038,SYNTH_04,DONOR_0068,,TREATMENT_0135,"{'day_interval': 699, 'month_interval': 22}",Progression not otherwise specified,Distant recurrence/metastasis,"{'day_interval': 123, 'month_interval': 4}",Histopathology test (procedure)|Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0039,SYNTH_04,DONOR_0069,,,"{'day_interval': 575, 'month_interval': 18}",Progression not otherwise specified,Local recurrence and distant metastasis,"{'day_interval': 74, 'month_interval': 2}",Tumor marker measurement (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0040,SYNTH_04,DONOR_0070,DIAG_0070,,"{'day_interval': 1551, 'month_interval': 50}",,Local recurrence,,Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_NULL_0001,SYNTH_01,DONOR_NULL_0001,,TREATMENT_NULL_0001,,,,,,
FOLLOW_UP_NULL_0002,SYNTH_01,DONOR_NULL_0002,,,"{'day_interval': 677, 'month_interval': 22}",,,,,
FOLLOW_UP_ALL_0001,SYNTH_01,DONOR_ALL_0001,DIAG_ALL_0001,,"{'day_interval': 8459, 'month_interval': 277}",Relapse or recurrence,Biochemical progression,,Histopathology test (procedure)|Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_ALL_0002,SYNTH_01,DONOR_ALL_0002,,TREATMENT_ALL_0003,"{'day_interval': 1005, 'month_interval': 33}",No evidence of disease,Local recurrence,,Imaging (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
